Literature DB >> 27476616

Differences in availability of cancer drugs across Europe.

Susan Mayor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27476616     DOI： 10.1016/S1470-2045(16)30378-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.

Authors:  Alice Pisana; Björn Wettermark; Amanj Kurdi; Biljana Tubic; Caridad Pontes; Corinne Zara; Eric Van Ganse; Guenka Petrova; Ileana Mardare; Jurij Fürst; Marta Roig-Izquierdo; Oyvind Melien; Patricia Vella Bonanno; Rita Banzi; Vanda Marković-Peković; Zornitsa Mitkova; Brian Godman
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

2.  Metastatic anorectal melanomas - An exploratory retrospective analysis on the benefits of systemic therapy versus best supportive care in a resource-limited setting from India.

Authors:  Arvind Sahu; Anant Ramaswamy; Nitin Singhal; Vipul Doshi; Jimmy Mirani; Ashwin Desouza; Shripad Banavali; Avanish Saklani; Vikas Ostwal
Journal:  South Asian J Cancer       Date:  2017 Oct-Dec

3.  Global cancer control: responding to the growing burden, rising costs and inequalities in access.

Authors:  Gerald W Prager; Sofia Braga; Branislav Bystricky; Camilla Qvortrup; Carmen Criscitiello; Ece Esin; Gabe S Sonke; Guillem Argilés Martínez; Jean-Sebastian Frenel; Michalis Karamouzis; Michiel Strijbos; Ozan Yazici; Paolo Bossi; Susana Banerjee; Teresa Troiani; Alexandru Eniu; Fortunato Ciardiello; Josep Tabernero; Christoph C Zielinski; Paolo G Casali; Fatima Cardoso; Jean-Yves Douillard; Svetlana Jezdic; Keith McGregor; Gracemarie Bricalli; Malvika Vyas; André Ilbawi
Journal:  ESMO Open       Date:  2018-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.